• Jatinder Kaur's avatar
    • Articles
    • Views
    EDITOR

    Jatinder Kaur

    Jatinder Kaur is a veteran online health and social research journalist at ABC Live, based in Chandigarh, India. With a Master’s in Philosophy and over 16 years of experience since 2008, she specializes in in-depth reporting on public health and societal issues.

Author's Posts

  • Explained: India’s New National Cooperative Policy 2025

    Explained: India’s New National Cooperative Policy 20250

    India’s New National Cooperative Policy 2025 aims to transform the cooperative sector through six strategic pillars, digital infrastructure, and stronger governance. This ABC Live explainer examines the policy’s roadmap, data, and potential impact on India’s cooperative economy.

    READ MORE
  • Critical Review of NOTTO: India’s Organ Transplant System

    Critical Review of NOTTO: India’s Organ Transplant System0

    India’s organ transplant numbers are rising fast. However, growth alone does not guarantee a strong system. This ABC Live critical review examines how NOTTO actually functions, what data is missing, how courts shape transplant law, and what India must fix to become a global leader in ethical organ transplantation.

    READ MORE
  • Explained: How States Perform Under National Health Authority

    Explained: How States Perform Under National Health Authority0

    India’s National Health Authority runs one of the world’s largest health insurance and digital health programmes. However, when the data is examined State by State, outcomes diverge sharply. This explainer breaks down PM-JAY and ABDM performance using verified data, state-wise scorecards, and clear analysis to show why healthcare results depend more on State capacity than on national design.

    READ MORE
  • Critical Analysis of NDCT Amendments 2026

    Critical Analysis of NDCT Amendments 20260

    In January 2026, the Union Government amended the New Drugs and Clinical Trials (NDCT) Rules, 2019 to reduce regulatory delays and promote pharmaceutical R&D. By replacing test licences with prior intimation for non-commercial manufacture and waiving prior approval for certain low-risk BA/BE studies, the reforms promise faster timelines and lower compliance friction. However, the changes also mark a deeper shift—from permission-based control to trust-based, post-facto regulation—placing greater legal and compliance responsibility on sponsors and CROs. This explainer examines what changed, why it matters, and how India’s new NDCT framework compares globally.

    READ MORE